Sable Bio vs Spark Therapeutics
Sable Bio vs Spark Therapeutics, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Sable Bio is on 41/100 and Spark Therapeutics on 58/100.
Where each one leads
Sable Bio
- agent readiness: 44/100 against 39/100
Spark Therapeutics
- our overall score: 58/100 against 41/100
- domain rating: 80/100 against 15/100
- funding raised: $82.8M against $3.1M
At a glance
| Measure | Sable Bio | Spark Therapeutics |
|---|---|---|
| What it is | AI drug safety startup | A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases. |
| Category | Biotechnology, Artificial Intelligence, Drug Discovery, Pharmaceuticals | Biotechnology, Gene Therapy, Healthcare, Pharmaceuticals |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2022 | 2013 |
| Headquarters | London, United Kingdom | Philadelphia, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Sable Bio | Spark Therapeutics |
|---|---|---|
| Total funding | $3.1M | $82.8M |
| Latest round | Unknown | Series B |
| Valuation | $1.1B | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Sable Bio | Spark Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 41/100 | 58/100 |
| Traction | 32/100 | 40/100 |
| Team | Not published | 90/100 |
| Search visibility | 11/100 | 13/100 |
| Quality | 58/100 | 65/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (44/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 15/100 | 80/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Sable Bio | Spark Therapeutics |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | Framer | Not detected |
| Frameworks | Not detected | Jquery |
| Analytics | Google Analytics 4 | Google Tag Manager |
What users say
| Measure | Sable Bio | Spark Therapeutics |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 1 positive, 0 negative across 3 threads |
“The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche's Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings.”r/conspiracy
Sable Bio vs Spark Therapeutics: common questions
Which is better, Sable Bio or Spark Therapeutics?
On our 0-100 score Spark Therapeutics rates higher (58/100 against 41/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do Sable Bio and Spark Therapeutics compare on the numbers?
Sable Bio leads on agent readiness (44/100 against 39/100). Spark Therapeutics leads on our overall score (58/100 against 41/100), domain rating (80/100 against 15/100), funding raised ($82.8M against $3.1M).
What do real users say about Sable Bio and Spark Therapeutics?
Spark Therapeutics: 1 positive and 0 negative mentions across 3 Reddit threads we track, mostly in r/conspiracy.
Read the full Sable Bio review and pricing or the Spark Therapeutics review and pricing. You can also browse other Sable Bio alternatives we track.